LMF
FLNA

LMR Master Fund’s Filana Therapeutics FLNA Stock Holding History

LMR Master Fund’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$109K Buy
+3,209
New +$85.2K 0.01% 326
2013
Q3 		– Sell
-15,278
Closed -$237K – 407
2013
Q2 		$237K Buy
+15,278
New +$323K 0.02% 353

Other funds holding FLNA

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
MSP
Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

LMR Master Fund's FLNA Position: Q4 2013 in Review

LMR Master Fund opened a new position in Filana Therapeutics (FLNA) in Q4 2013: 3,209 shares worth $109K. The stake represents 0.01% of the portfolio and ranks #326 among its holdings. This is a return to the name: LMR Master Fund previously reported a position in FLNA as recently as Q2 2013.

LMR Master Fund first reported a position in FLNA in Q2 2013 and has held it in 2 quarters since. The position peaked at $237K in Q2 2013. 62 funds tracked by Wall St. Rank hold FLNA as of Q4 2013.

  • LMR Master Fund held 3,209 shares of Filana Therapeutics worth $109K as of Q4 2013.
  • Filana Therapeutics was a new LMR Master Fund position in Q4 2013.
  • Filana Therapeutics made up 0.01% of LMR Master Fund's portfolio in Q4 2013, its #326 holding.
  • LMR Master Fund first reported a position in Filana Therapeutics in Q2 2013 and has held it in 2 quarters since.
  • LMR Master Fund's Filana Therapeutics position peaked at $237K in Q2 2013.
  • 62 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.